Journal Article Review Epublish 25 citations
PubMed: 38400174 DOI: 10.3390/vaccines12020191
Vaccine Strategies to Elicit Mucosal Immunity.
Vaccines (Basel) 12(2)
Authors: Yufeng Song, Frances Mehl, Steven L Zeichner
Affiliations
- Department of Pediatrics, University of Virginia, Charlottesville, VA 22908, USA.
- Department of Microbiology, Immunology, and Cancer Biology, University of Virginia, Charlottesville, VA 22908, USA.
Abstract
Vaccines are essential tools to prevent infection and control transmission of infectious diseases that threaten public health. Most infectious agents enter their hosts across mucosal surfaces, which make up key first lines of host defense against pathogens. Mucosal immune responses play critical roles in host immune defense to provide durable and better recall responses. Substantial attention has been focused on developing effective mucosal vaccines to elicit robust localized and systemic immune responses by administration via mucosal routes. Mucosal vaccines that elicit effective immune responses yield protection superior to parenterally delivered vaccines. Beyond their valuable immunogenicity, mucosal vaccines can be less expensive and easier to administer without a need for injection materials and more highly trained personnel. However, developing effective mucosal vaccines faces many challenges, and much effort has been directed at their development. In this article, we review the history of mucosal vaccine development and present an overview of mucosal compartment biology and the roles that mucosal immunity plays in defending against infection, knowledge that has helped inform mucosal vaccine development. We explore new progress in mucosal vaccine design and optimization and novel approaches created to improve the efficacy and safety of mucosal vaccines.
MeSH
Infections, Vaccines, Immunity, Mucosal
Cited by
- New insights for the development of efficient DNA vaccines. Microb Biotechnol, 2024
- Revolutionizing Dentistry: Preclinical Insights and Future Applications of mRNA Vaccines in Dentistry-A Narrative Review. Dent J (Basel), 2025
- Comparative Efficacy of Parenteral and Mucosal Recombinant Probiotic Vaccines Against SARS-CoV-2 and Infections in Animal Models. Vaccines (Basel), 2024
- Mucosal immunity and vaccination strategies: current insights and future perspectives. Mol Biomed, 2025
- A Narrative Review of Periodontal Vaccines: Hope or Hype? Cureus, 2025
- Double-layered protein nanoparticles conjugated with truncated flagellin induce improved mucosal and systemic immune responses in mice. Nanoscale Horiz, 2024
- Evaluation of dual pathogen recognition receptor agonists as adjuvants for respiratory syncytial virus - virus-like particles for pulmonary delivery. Front Immunol, 2025
- Next-generation adjuvant systems containing furfurman drives potent adaptive immunity and host defense as a foot-and-mouth disease vaccine adjuvant. Front Immunol, 2025
- ASIA Syndrome: State-of-the-Art and Future Perspectives. Vaccines (Basel), 2024
- Glycemic control and vaccine response: the role of mucosal immunity after vaccination in diabetic patients. Front Immunol, 2025
- In Silico Subtractive Proteome Analysis to Design Multi-Epitope-Based Subunit Vaccine against . J Microbiol Biotechnol, 2025
- Chlamydia muridarum mutant CM-pGP3S as a novel attenuated live rectal vaccine protects against genital tract infection. Front Cell Infect Microbiol, 2025
- Advancing veterinary vaccines design through trained immunity insights. Front Vet Sci, 2025
- Nanotechnology-driven advances in intranasal vaccine delivery systems against infectious diseases. Front Immunol, 2025